Stay updated with breaking news from Tprds. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SVB Securities downgraded shares of Pardes Biosciences (NASDAQ:PRDS – Get Rating) from an outperform rating to a market perform rating in a report published on Tuesday, The Fly reports. Several other equities research analysts also recently commented on PRDS. JMP Securities reduced their target price on Pardes Biosciences from $9.00 to $5.00 and set a […]
Jefferies Financial Group lowered shares of Pardes Biosciences (NASDAQ:PRDS – Get Rating) from a buy rating to a hold rating in a research note issued to investors on Monday, The Fly reports. Jefferies Financial Group also issued estimates for Pardes Biosciences’ Q2 2023 earnings at ($0.36) EPS, Q3 2023 earnings at ($0.27) EPS, Q4 2023 […]
Pardes Biosciences, Inc. (NASDAQ:PRDS – Get Rating) – Research analysts at Jefferies Financial Group decreased their Q2 2023 EPS estimates for Pardes Biosciences in a research report issued on Monday, April 3rd. Jefferies Financial Group analyst D. Ding now expects that the company will earn ($0.36) per share for the quarter, down from their previous […]
Pardes Biosciences (NASDAQ:PRDS – Get Rating) was downgraded by stock analysts at SVB Securities from an “outperform” rating to a “market perform” rating in a report released on Tuesday, The Fly reports. Several other brokerages also recently commented on PRDS. JMP Securities reduced their target price on Pardes Biosciences from $9.00 to $5.00 and set […]
Pardes Biosciences, Inc. (NASDAQ:PRDS – Get Rating) – Investment analysts at SVB Leerink decreased their Q1 2023 earnings per share estimates for Pardes Biosciences in a report issued on Monday, April 3rd. SVB Leerink analyst R. Ruiz now forecasts that the company will earn ($0.38) per share for the quarter, down from their previous estimate […]